Abbisko Therapeutics Co, Ltd clinical trials
A subsidiary of Abbisko Cayman Limited
The registry lists 38 studies whose lead sponsor is Abbisko Therapeutics Co, Ltd. 20 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 4, 2026.
Status
Registry sponsor names on this page
- Abbisko Therapeutics Co, Ltd38 studies
Something wrong with this grouping? Tell us on the Abbisko Cayman Limited page.
Studies
Recruiting first, then most recently updated. Showing 38 of 38. All Abbisko Cayman Limited studies →
- A Phase I Study of ABSK211 in Participants With Advanced Solid Tumors With KRAS AlterationRecruitingNCT07718165Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Study to Evaluate the Effects of Low-Fat Meal, High-Fat Meal and Omeprazole Enteric-Coated Tablets on the Pharmacokinetics of ABSK-011 Capsules in Healthy ParticipantsRecruitingNCT07700953Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Phase 2 Study of ABSK043 Combined With OsimertinibNot yet recruitingNCT07710612Phase 2
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Phase 2 Clinical Study of Combination Therapy With ABSK043 and GlecirasibRecruitingNCT07164170Phase 2
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid TumorRecruitingNCT04906434Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid TumorRecruitingNCT04192344Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Phase I/II Study of ABSK141 in Patients With Advanced Solid Tumors ( ABSK141-101 )RecruitingNCT07417189Phase 1/2
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC PatientsEnrolling by invitationNCT05441475Phase 2
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- ABSK-011+BSC vs. Placebo+BSC in Previously Treated Advanced HCC With FGF19 OverexpressionRecruitingNCT07327034Phase 2
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Study in Children With AchondroplasiaRecruitingNCT07301463
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Study of ABSK061 to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy in Children With AchondroplasiaNot yet recruitingNCT07297875Phase 1/2
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid TumorsRecruitingNCT07288957Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Mass Balance Study of [14C]ABSK011Not yet recruitingNCT06896760Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Phase 2 Clinical Study of Combination Therapy With ABSK043 and FirmonertinibRecruitingNCT06668103Phase 2
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Phase 2 Clinical Study of ABSK061 and ABSK043RecruitingNCT06632262Phase 2
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chronic Graft Versus Host Disease (cGvHD)Enrolling by invitationNCT06186804Phase 2
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid TumorsRecruitingNCT05244551Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic CancerRecruitingNCT06111274Phase 2
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung CancerRecruitingNCT06225804Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUCRecruitingNCT05775874Phase 2
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABSK061 Mini-tablets in Healthy Adult ParticipantsCompletedNCT07007546Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)Active, not recruitingNCT05804045Phase 3
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Clinical Trial to Evaluate the Relative Bioavailability of New and Old ABSK-011 CapsulesCompletedNCT06306872Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Study to Evaluate the Relative Bioavailability of Pimicotinib Capsules Containing Free Base in Different Proportions in Healthy SubjectsCompletedNCT07210996Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid TumorsActive, not recruitingNCT05627063Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Study to Evaluate the the Bioequivalence of Two Different Pimicotinib Capsules in Healthy SubjectsCompletedNCT07126249Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Study to Investigate The Effect of Pimicotinib on The Pharmacokinetics of Metformin, Fexofenadine and Rosuvastatin In Healthy SubjectsCompletedNCT06779253Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Study to Evaluate the Effect of a High-fat Meal on the Exposure of Pimicotinib Capsule in Healthy SubjectsActive, not recruitingNCT06884072Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Clinical Trial to Evaluate a High-Fat Meal and Omeprazole Enteric-coated Tablets on ASBK021CompletedNCT06322706Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Study to Evaluate the Relative Bioavailability of Two Different Pimicotinib Capsules in Healthy SubjectsCompletedNCT06694948Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- The Study to Assess the Pharmacokinetics of Pimicotinib in Subjects With Mild and Moderate Hepatic Impairment Relative to Subjects With Normal Hepatic FunctionCompletedNCT06562946Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Mass Balance Study of [14C]ABSK021CompletedNCT06186583Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- ABSK021 Food Effect Study in Healthy SubjectsCompletedNCT05280483Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Clinical Trial to Evaluate the Effect of Itraconazole and Rifampicin on ABSK021CompletedNCT06089733Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- ABSK091 Food Effect Study in Healthy SubjectsCompletedNCT05533788Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK043 in Patients With Advanced Solid TumorStatus unknownNCT04964375Phase 1
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Study to Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBCStatus unknownNCT05103917Phase 1/2
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd
- A Phase 1b/2 Clinical Study to Evaluate the Safety and Tolerability and Efficacy of AZD4547Status unknownNCT05086666Phase 1/2
Sponsor listed in the registry: Abbisko Therapeutics Co, Ltd